The novel capsazepine analog, CIDD-99, significantly inhibits oral squamous cell carcinoma in vivo through a TRPV1-independent induction of ER stress, mitochondrial dysfunction, and apoptosis

  • Jorge J. De La Chapa
  • , Prajjal K. Singha
  • , Kristen K. Self
  • , McKay L. Sallaway
  • , Stanton F. McHardy
  • , Matthew J. Hart
  • , Howard S Mcguff
  • , Matthew C. Valdez
  • , Francisco Ruiz
  • , Srikanth R. Polusani
  • , Cara B. Gonzales

Research output: Contribution to journal › Article › peer-review

12 Scopus citations

Fingerprint

Dive into the research topics of 'The novel capsazepine analog, CIDD-99, significantly inhibits oral squamous cell carcinoma in vivo through a TRPV1-independent induction of ER stress, mitochondrial dysfunction, and apoptosis'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science